Status:
TERMINATED
Infiltration Effect on SUV
Lead Sponsor:
Wake Forest University Health Sciences
Collaborating Sponsors:
Lucerno Dynamics, LLC
Conditions:
Dose Response Relationship, Drug
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
A widely used semi-quantitative parameter to assess tumor status is the standardized uptake value (SUV). SUV estimation accuracy can be impacted by many variables. Today there still exists a significa...
Eligibility Criteria
Inclusion
- Subjects with solid tumors undergoing PET/CT scan who have at least one measurable target lesion and sustain a moderate or greater infiltration.
Exclusion
- Subjects unwilling or unable to tolerate a repeat PET/CT scan.
- Subjects with meaningful medical intervention between PET/CT scans that would likely impact SUV.
- Subjects with follow up injection infiltrations that would likely impact the SUV.
- Pregnant patients.
Key Trial Info
Start Date :
August 27 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 13 2019
Estimated Enrollment :
2 Patients enrolled
Trial Details
Trial ID
NCT03320564
Start Date
August 27 2018
End Date
February 13 2019
Last Update
March 18 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Wake Forest Baptist Health
Winston-Salem, North Carolina, United States, 27157